T-cell-associated antigens such as PD-L1 and FOXP3 have been shown to negatively impact MCL outcome [12], emphasizing the therapeutic potential for checkpoint inhibitors in subgroups of patients. Here, CD274 is linked to mantle cell lymphoma.